Search details
1.
RAF inhibitor re-challenge therapy in BRAF-aberrant pan-cancers: the RE-RAFFLE study.
Mol Cancer
; 23(1): 64, 2024 03 26.
Article
in English
| MEDLINE | ID: mdl-38532456
Results
1 -
1
de 1
1
Next >
>>